National Coverage Determination updates

Get updates on your Medicare coverage

The Centers for Medicare & Medicaid Services (CMS) periodically changes coverage rules for items and/or services. These changes are communicated through National Coverage Determinations (NCDs) updates.

See detailed NCD information or call Member Services at 1-877-232-7566 (TTY: 711), 8 am to 8 pm weekdays (year-round) and weekends (Oct. 1 – March 31).

The following list summarizes the most recent NCD updates:
 

LEADLESS PACEMAKERS

  • CMS retroactive effective date: Jan. 18, 2017
  • CMS implementation date: Aug. 29, 2017
Effective with dates of service 01/18/2017, CMS will cover leadless pacemakers through Coverage with Evidence Development (CED) when procedures are performed in CMS-approved CED studies.

For complete National Coverage Determination information, see NCD 20.8.4.
 

SCREENING FOR HEPATITIS B VIRUS (HBV) INFECTION

  • CMS retroactive effective date: Sept. 28, 2016
  • CMS implementation date: Jan. 2, 2018
Effective with dates of service 09/28/2016, CMS has determined that screening for HBV infection will be covered with the appropriate U.S. Food and Drug Administration (FDA) approved/cleared laboratory tests, used consistent with FDA-approved labeling and in compliance with the Clinical Laboratory Improvement Act (CLIA) regulations.

For complete National Coverage Determination information, see NCD 210.6.
 

PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE

  • CMS retroactive effective date: Feb. 8, 2016
  • CMS implementation date: Oct. 3, 2016
Effective with dates of service 02/08/2016, CMS will cover Percutaneous Left Atrial Appendage Closure (LAAC) through Coverage with Evidence Development (CED) when LAAC is furnished in patients with Non-Valvular Atrial Fibrilation (NVAF) and according to an FDA approved indication for percutaneous LAAC with an FDA-approved device. 

For complete National Coverage Determination information, see NCD 20.34.